首页> 中文期刊>中华放射肿瘤学杂志 >食管癌根治性调强放疗大体肿瘤体积因素与靶区内放疗失败的关系

食管癌根治性调强放疗大体肿瘤体积因素与靶区内放疗失败的关系

摘要

Objective Investigate the relationship between gross tumor volume (GTV)-related factors including GTV-T volume,the maximum thickness of the esophageal lesion plane and GTV-T volume/length(GTV-T volume divided by the length of the lesion calculated by the number of GTV-T layers) and the locoregional failure of radical intensity-modulated radiation therapy (IMRT) for esophageal carcinoma.Methods A total of 133 patients with esophageal cancer undergoing radical IMRT were enrolled.The factors related to GTV-T including GTV-T volume,the maximum thickness of the esophageal lesions,GTV-T volume/length were calculated.The relationship between GTV-T related factors and local recurrence of tumors was retrospectively analyzed.Results There was positively linear association between the locoregional failure rate of GTV-T and the volume of GTV-T.The volume of GTV-T tumor was 36 cm3,the maximum wall thickness was 2.5 cm,and the GTV-T volume/length was calculated as 5.3 cm2.These critical values could be utilized to predict the risk of locoregional failure of IMRT for esophageal carcinoma.Conclusions The GTV-T factors can be adopted to predict the local control and the risk of locoregional failure of radical IMRT for esophageal carcinoma to certain extent.%目的 回顾性分析GTV-T因素与肿瘤局部失败的关系.方法 整理并计算133例行根治性调强放疗的食管癌患者GTV-T因素.包括:GTV-T体积,GTV-T最大管壁厚度(GTV-T区域中食管平面最大厚度),GTV-T体积/长度(GTV-T体积除以GTV-T层面数计算病变长度).结果 GTV-T区域治疗失败率与GTV-T体积呈正相关线性趋势关系.GTV-T肿瘤体积为36 cm3,最大管壁厚度为2.5cm,以及体积/长度为5.3 cm2,可作为预估食管癌放疗失败风险的临界值.结论 根治性调强放疗大体肿瘤体积(GTV-T)因素能在一定程度上预示食管癌根治性放疗后局部控制情况,预估食管癌的放疗失败风险.

著录项

  • 来源
    《中华放射肿瘤学杂志》|2019年第2期|85-89|共5页
  • 作者单位

    Department of Radiobiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Medical Research Center for Cancer, Tianjin, Tianjin 300060, China;

    Department of Gynecology, Tianjin Central Hospital of Gynecology and Obstetrics, Tianjin 300100, China;

    Department of Radiobiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Medical Research Center for Cancer, Tianjin, Tianjin 300060, China;

    Department of Radiobiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Medical Research Center for Cancer, Tianjin, Tianjin 300060, China;

    Department of Radiobiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Medical Research Center for Cancer, Tianjin, Tianjin 300060, China;

    Department of Radiobiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Medical Research Center for Cancer, Tianjin, Tianjin 300060, China;

    Department of Radiobiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Medical Research Center for Cancer, Tianjin, Tianjin 300060, China;

    Department of Radiobiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Medical Research Center for Cancer, Tianjin, Tianjin 300060, China;

    Department of Radiobiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Medical Research Center for Cancer, Tianjin, Tianjin 300060, China;

    Department of Radiobiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Medical Research Center for Cancer, Tianjin, Tianjin 300060, China;

    Department of Gynecology, Tianjin Central Hospital of Gynecology and Obstetrics, Tianjin 300100, China;

    Department of Radiobiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Medical Research Center for Cancer, Tianjin, Tianjin 300060, China;

    Department of Radiobiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Medical Research Center for Cancer, Tianjin, Tianjin 300060, China;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类
  • 关键词

    食管肿瘤/调强放射疗法; 大体肿瘤体积; 管壁厚度;

  • 入库时间 2023-07-25 14:59:00

相似文献

  • 中文文献
  • 外文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号